Comparative Analysis of β-Carotene Hydroxylase Genes for Astaxanthin Biosynthesis

Fermentation and Metabolic Engineering Group, Ocean Nutrition Canada Ltd., 101 Research Drive, Dartmouth, Nova Scotia, Canada.
Journal of Natural Products (Impact Factor: 3.8). 05/2012; 75(6):1117-24. DOI: 10.1021/np300136t
Source: PubMed


Astaxanthin (3,3'-dihydroxy-4,4'-diketo-β-carotene) (1) is a carotenoid of significant commercial value due to its superior antioxidant potential, application as a component of animal feeds, and ongoing research that links its application to the treatment and prevention of human pathologies. The high commercial cost of 1 is also based upon its complex synthesis. Chemical synthesis has been demonstrated, but produces a mixture of stereoisomers with limited applications. Production from biological sources is limited to natural producers with complex culture requirements. The biosynthetic pathway for 1 is well studied; however, questions remain that prevent optimized production in heterologous systems. Presented is a direct comparison of 12 β-carotene (2) hydroxylases derived from archaea, bacteria, cyanobacteria, and plants. Expression in Escherichia coli enables a comparison of catalytic activity with respect to zeaxanthin (3) and 1 biosynthesis. The most suitable β-carotene hydroxylases were subsequently expressed from an efficient dual expression vector, enabling 1 biosynthesis at levels up to 84% of total carotenoids. This supports efficient 1 biosynthesis by balanced expression of β-carotene ketolase and β-carotene hydroxylase genes. Moreover, our work suggests that the most efficient route for astaxanthin biosynthesis proceeds by hydroxylation of β-carotene to zeaxanthin, followed by ketolation.

18 Reads
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Carotenoids are nutritionally-beneficial organic tetraterpenoid pigments synthesized mainly by plants, bacteria and fungi. Although research has focused on the production of carotenoids in staple crops to improve nutritional welfare in developing countries, there is also an enormous market for carotenoids in the industrialized world, where they are produced both as commodities and luxury goods targeted at the pharmaceutical, nutraceutical, food/feed additive, cosmetics and fine chemicals sectors. Carotenoids are economically valuable because they have diverse bioactive and chemical properties. Some are essential nutrients (e.g. β-carotene), others are antioxidants with specific roles (e.g. lutein and zeaxanthin) or general health-promoting roles that reduce the risk or progression of diseases associated with oxidative stress (e.g. lycopene), and still others are natural pigments (e.g. astaxanthin, which is added to fish feed to impart a desirable pink flesh color). Even carotenoid degradation products, such as damascones and damascenones, are used as fragrances in the perfumes industry. Here we discuss the importance of carotenoids in different market sectors, review current methods for commercial production and its regulation, summarize the most relevant patents and consider evidence supporting the health claims made by different industry sectors, focusing on case studies representing the most commercially valuable carotenoids on the market: β-carotene, lycopene, lutein, zeaxanthin and astaxanthin.
    Phytochemistry Reviews 07/2014; 14(5). DOI:10.1007/s11101-014-9373-1 · 2.41 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: L. barbarum contains high contents of zeaxanthin, which is produced by conversion of β-carotene into zeaxanthin. β-Carotene hydroxylase catalyzes this reaction. We cloned a cDNA (chyb) encoding β-carotene hydroxylase (Chyb) from L. barbarum leaf. A 939-bp full-length cDNA sequence was determined with 3’-Rapid Amplification of cDNA End (3’-RACE) assay encoding a deduced Chyb protein (34.8 kDa) with a theoretical pI 8.36. Bioinformatics analysis showed that the L. barbarum Chyb located in the chloroplast. Further, to investigate the catalytic activity of L. barbarum Chyb, complementation analysis was conducted in Escherichia coli. The results strongly demonstrated that Chyb chould catalyze β-carotene to produce zeaxanthin. Thus, this study suggests that L. barbarum β-carotene hydroxylase could be a means of zeaxanthin production by genetic manipulation in Escherichia coli.This article is protected by copyright. All rights reserved
    Biotechnology and Applied Biochemistry 11/2014; 61(6). DOI:10.1002/bab.1224 · 1.36 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Astaxanthin, a high value ketocarotenoid used in the pharmaceutical and nutraceutical industries is mainly produced from green alga, Haematococcus pluvialis. It is biosynthesized by the action of key enzyme, β-carotene ketolase (BKT) on β-carotene through intermediates echinenone and canthaxanthin. In this study, the (-carotene ketolase (bkt) gene was isolated from H. pluvialis and cloned in a vector pRT100 and further mobilized to a binary vector pCAMBIA 1304. The T-DNA of pCAMBIA 1304, which consists of cloned bkt was successfully transformed to H. pluvialis through Agrobacterium mediation. The cloning and transformation of bkt in H. pluvialis was confirmed by southern blotting and also by PCR analysis. Total carotenoids and astaxanthin content in the transformed cells were found to be two to three fold higher while the intermediates like echinenone and canthaxanthin were found to be eight to ten fold higher than in the control cells. The expression level of carotenogenic genes like phytoene synthase (psy), phytoene desaturase (pds), lycopene cyclase (lcy), bkt, and β-carotene hydroxylase (bkh) were found to be higher in transformed cells compared to the non-transformed (NT) H. pluvialis. Copyright © 2015. Published by Elsevier B.V.
    Journal of Biotechnology 01/2015; 196-197. DOI:10.1016/j.jbiotec.2015.01.006 · 2.87 Impact Factor
Show more